Chelated metal ions for therapeutic and diagnostic applications.
Use of radiolabeled monoclonal antibodies (mAb's) that localize and bind to malignant cells continues to be an attractive mechanism for targeting and delivering either an imagable isotope, be it a y-emitter or B(+)-emitter, or a particle emitter such as a B(-)-emitter or an a-emitter for therapeutic applications.